A Method for Conducting Highly Sensitive MicroRNA In Situ Hybridization and Immunohistochemical Analysis in Pancreatic Cancer
Profiling experiments in whole tissue biopsies have linked altered expression of microRNAs (miRNAs) to different types of cancer, including pancreatic ductal adenocarcinoma (PDAC). Emerging evidence indicates that altered miRNA expression can occur in different cellular compartments (cancer and non-cancer cells) in tumor lesions, and thus it is important to ascertain which specific cell type expresses a particulars miRNA in PDAC tissues. Here, we describe a highly sensitive fluorescence-based ISH method to visualize miRNA accumulation within individual cells in formalin-fixed paraffin-embedded (FFPE) tissue sections using 5′ and 3′ terminally fluorescein-labeled locked nucleic acid (LNA)-modified probes. We describe a multicolor ISH/IHC method based on sequential rounds of horseradish peroxidase (HRP)-mediated tyramide signal amplification (TSA) reactions with different in-house synthesized fluorochrome-conjugated substrates that enable co-detection of miRNAs, abundant noncoding RNAs and protein markers for signal quantification, and cell type co-localization studies in FFPE pancreatic tissue sections from clinical specimens and mouse models of PDAC.
- Deep Transcriptome Profiling of Ovarian Cancer Cells Using Next-Generation Sequencing Approach
- The EGFR Pathway as an Example for Genotype: Phenotype Correlation in Tumor Genes
- Pharmacokinetic and Pharmacodynamic Implications of P-Glycoprotein Modulation
- Cytokine Multiplex Analysis
- Sequencing of the Tumor Suppressor Gene TP 53
- Microdissection and Extraction of DNA From Archival Tissue
- Detection of ErbB Receptor Family Tyrosyl Phosphorylation in Ovarian Carcinoma Cells
- Selective Immortalization of Tumor-Specific T Cells to Establish Long-Term T-Cell Lines Maintaining Primary Cell Characteristics
- Chromogenic In Situ Hybridization in Tumor Pathology
- 细胞因子的检测方法